Benjamin L Palleiko - Net Worth and Insider Trading
Benjamin L Palleiko Net Worth
The estimated net worth of Benjamin L Palleiko is at least $3 Million dollars as of 2024-06-20. Benjamin L Palleiko is the CHIEF EXECUTIVE OFFICER of KalVista Pharmaceuticals Inc and owns about 224,547 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $3 Million. Details can be seen in Benjamin L Palleiko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benjamin L Palleiko has not made any transactions after 2024-06-07 and currently still holds the listed stock(s).
Transaction Summary of Benjamin L Palleiko
Benjamin L Palleiko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin L Palleiko owns 2 companies in total, including KalVista Pharmaceuticals Inc (KALV) , and Ore Holdings Inc (ORXE) .
Click here to see the complete history of Benjamin L Palleiko’s form 4 insider trades.
Insider Ownership Summary of Benjamin L Palleiko
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KALV | KalVista Pharmaceuticals Inc | 2024-06-07 | CFO and Secretary |
ORXE | Ore Holdings Inc | 2010-01-18 | SVP & Chief Financial Officer |
Benjamin L Palleiko Latest Holdings Summary
Benjamin L Palleiko currently owns a total of 1 stock. Benjamin L Palleiko owns 224,547 shares of KalVista Pharmaceuticals Inc (KALV) as of June 7, 2024, with a value of $3 Million.
Latest Holdings of Benjamin L Palleiko
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KALV | KalVista Pharmaceuticals Inc | 2024-06-07 | 224,547 | 11.37 | 2,553,099 |
Holding Weightings of Benjamin L Palleiko
Benjamin L Palleiko Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin L Palleiko has made a total of 12 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 7,465 shares on June 7, 2024, which brought Benjamin L Palleiko around $86,072.
Insider Trading History of Benjamin L Palleiko
- 1
Benjamin L Palleiko Trading Performance
Benjamin L Palleiko Ownership Network
Ownership Network List of Benjamin L Palleiko
Ownership Network Relation of Benjamin L Palleiko
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Benjamin L Palleiko Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Benjamin L Palleiko is the CFO and Secretary of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , Chief Development Officer Christopher Yea , and Chief Scientific Officer Edward P. Feener .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Benjamin L Palleiko made 8 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 128,147. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 118,495 shares made by Edward P. Feener , and a net sale of 165,254 shares made by Thomas Andrew Crockett .
In summary, during the past 3 months, insiders sold 62,297 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 62,297 shares. During the past 18 months, 562,698 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 688,319 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Benjamin L Palleiko Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin L Palleiko. You might contact Benjamin L Palleiko via mailing address: C/o Kalvista Pharmaceuticals, Inc., One Kendall Square, Bld 200, Ste 2203, Cambridge Ma 02139.